19- hypokalemia

Cards (18)

  • Potassium

    • Most of the body's potassium is intracellular
    • Serum levels are controlled by: uptake of K+ into cells, renal excretion (controlled mainly by aldosterone), and extrarenal losses (e.g. gastrointestinal)
  • Hypokalemia
    Serum K concentration of <3.5 mmol/L
  • Causes of hypokalemia

    • Renal loss (diuretic treatment, steroids, hyperaldosteronism, Mg deficiency, metabolic alkalosis, DKA, RTA)
    • GI loss (diarrhea, vomiting, intestinal fistula, laxative abuse)
    • Shift into cells (alkalosis, increased insulin, beta adrenergic stimulation)
  • Hypokalemia
    • Leads to problems with muscular contraction and cardiac conduction
    • May be asymptomatic
    • Presents with weakness, paralysis, loss of reflexes (never presents with seizures)
    • Increases the risk of cardiac arrhythmias, especially in patients with cardiac disease
  • ECG findings in hypokalemia

    • U waves (most characteristic)
    • Ventricular ectopy (PVCs)
    • Flattened T waves
    • ST depression
  • Hypomagnesaemia
    • Makes it difficult to correct hypokalemia
    • Mg levels should be checked and normalized
  • Mild hypokalemia

    K 3.1-3.5
  • Treating mild hypokalemia

    1. Treat the underlying cause
    2. Withdrawal of laxatives
    3. Assessment of diuretic treatment
    4. Replacement with oral KCl supplements
  • Oral administration of potassium for mild hypokalemia
    10 to 20 mEq of potassium given two to four times per day (20 to 80 mEq/day)
  • Severe hypokalemia
    K <2.5-3.0 and symptomatic (arrhythmias, marked muscle weakness, or rhabdomyolysis)
  • Treating severe hypokalemia
    1. KCl given orally in doses of 40 mEq, three to four times per day
    2. Close monitoring every 2-4 hours
  • Indications for intravenous infusion of potassium chloride
    • Hypokalemic diabetic ketoacidosis
    • Severe hypokalemia associated with cardiac arrhythmias or muscle weakness not responsive to oral treatment
  • There is no maximum rate of oral potassium replacement
  • IV potassium replacement can cause a fatal arrhythmia if it is done too fast
  • Replacement rates of >20 mmol/hr should only be done with ECG monitoring & hourly measurement of serum K
  • The maximum amount of K that can be given by a peripheral line is 40 mmol/L
  • High concentrations (>60 mmol/L) should not be given through peripheral veins as they cause local irritation
  • Ampoules of potassium should be mixed in sodium chloride 0.9%, avoid glucose solutions as they make hypokalemia worse